San Diego biotech Escient Pharmaceuticals pulls in $120 million to advance therapy candidates
Startup biotech manages to raise venture capital despite a slowdown in funding amid economic uncertainty
Stay updated with breaking news from Column Group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Startup biotech manages to raise venture capital despite a slowdown in funding amid economic uncertainty
/PRNewswire/ -- The Southern California Biomedical Council (SoCalBio) -- the trade association for bioscience and digital health professionals across Greater...
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
California-based Hexagon Bio has closed a $47 million Series A funding round led by The Column Group, with participation from 8VC and Two Sigma Ventures.